Ask AI
ProCE Banner Activity

ExpressPoints: Multidisciplinary Perspectives Informing Optimal Treatment of RET-Altered Lung and Thyroid Cancer

Slideset Download
Download this short summary slideset of key takeaways from a live CCO Webinar featuring a molecular pathologist and medical oncologists with expertise in lung and thyroid cancer discussing the latest clinical data on optimal treatment of RET-altered disease with new-generation, selective RET inhibitors.

Released: April 13, 2021

Expiration: April 12, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lilly

Faculty Disclosure

Primary Author

Marcia Brose, MD, PhD, FASCO

Professor
Department of Medical Oncology
Sidney Kimmel Medical College
Thomas Jefferson University
Director, Sidney Kimmel Cancer Center
Vice Chair, Medical Oncology
Sidney Kimmel Medical College
Jefferson Northeast
Philadelphia, Pennsylvania

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

Laura J. Tafe, MD

Associate Professor of Pathology and Laboratory Medicine
Associate Director, Laboratory for Clinical Genomics and Advanced Technology and Director of Molecular Oncology
Dartmouth-Hitchcock Medical Center and the Geisel School of Medicine
Lebanon, New Hampshire